Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
NCT05756985 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-02-04
Summary
To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.
Conditions
- Glioblastoma
- Glioblastoma Multiforme
- Gliosarcoma
Interventions
- PROCEDURE
-
Specimen Collection
Collect and preserve glioblastoma tissue for exploratory analyses to generate hypotheses for future studies.
Sponsors & Collaborators
-
Miami Cancer Institute
collaborator OTHER -
Nico Corporation
collaborator INDUSTRY -
Baptist Health South Florida
lead OTHER
Principal Investigators
-
Manmeet S Ahluwalia, M.D. · Miami Cancer Institute at Baptist Health, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-11
- Primary Completion
- 2027-01-31
- Completion
- 2029-01-31
Countries
- United States
Study Locations
More Related Trials
-
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
NCT05281731 ·Status: RECRUITING ·Phase: NA
-
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200 ·Status: COMPLETED
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
NCT01135875 ·Status: COMPLETED
-
Preop fSRS for Resectable Brain Metastases
NCT05267587 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Liquid Biopsy in High-grade Gliomas and Meningiomas
NCT05630664 ·Status: UNKNOWN
-
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
NCT00001148 ·Status: COMPLETED
-
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
NCT04822688 ·Status: COMPLETED
-
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT06090903 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
NCT02851706 ·Status: COMPLETED
-
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
NCT00592709 ·Status: COMPLETED
-
Study of Stored Tumor Samples in Young Patients With Brain Tumors
NCT00897286 ·Status: TERMINATED
-
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours
NCT05025969 ·Status: COMPLETED
-
Role of the Tumor Microenvironment in Aggressive Meningiomas
NCT05821790 ·Status: UNKNOWN
-
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
NCT00581113 ·Status: TERMINATED ·Phase: PHASE3
-
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT03252171 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT06059690 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Supratotal Resection for Gliomas Within Noneloquent Areas
NCT02676687 ·Status: UNKNOWN ·Phase: NA
-
PH Sensitive MRI Based Resections of Glioblastoma
NCT06176066 ·Status: RECRUITING ·Phase: PHASE1
-
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
NCT05171127 ·Status: COMPLETED
-
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
NCT03115138 ·Status: TERMINATED ·Phase: NA
-
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
NCT02725684 ·Status: COMPLETED